India suspends production of cough syrups after reports suggest drug could cause child deaths

India halts production of cough syrups suspected of links to child deaths India has decided to suspend the production of all its cough syrups following reports suggesting that over a dozen of the products…

India suspends production of cough syrups after reports suggest drug could cause child deaths

India halts production of cough syrups suspected of links to child deaths

India has decided to suspend the production of all its cough syrups following reports suggesting that over a dozen of the products could be linked to child deaths.

The decision was taken on Monday by the state regulator and will be reviewed by a committee of experts formed to probe the issue, according to a statement from the state health department.

The decision was taken only after the regulator’s staff had collected information pertaining to 16 products containing the antihistamine dimenhydrinate.

Reports have suggested that these 16 products could have contained harmful quantities of the drug.

The regulator on Monday asked manufacturers to recall the entire range of cough syrups, which were made in Haryana and Chandigarh.

“The drug was used for decades to treat coughs, with no ill effects,” the regulator said.

“We have also found that 16 different products containing this drug were sold across the country, causing harm to a large number of children.”

The manufacturer of the cough syrups, the Indian Pediatrics Association, said the regulator’s decision was a good thing.

“The decision by regulators in West Bengal, Haryana and Chandigarh is a good step,” a spokesman told AFP.

“In India, more children are exposed to these cough syrups than in the rest of the world, as Indian children are given these cough syrups on every visit to the doctor,” he added.

The regulator has been asked to submit a report to it within two weeks with details of the incident and how the regulator came to its decision.

“The decision taken is temporary,” said state health minister Satyadev Shastri.

“The regulator and its team are very concerned about the safety of the cough syrups,” he told reporters.

The regulator has been asked to submit a report on the action taken

Leave a Comment